secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adicet Bio, Inc. (ACET)
CIK:        0001720580
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0000950170-23-026198
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adicet stockholders approve 2018 equity plan increase, elect directors at annual meeting
--------------------------------------------------------------------------------

- Elected Carl L. Gordon, Steve Dubin, and Jeffrey Chodakewitz as Class II directors for three-year terms.
- Approved Second Amended and Restated 2018 Stock Option and Incentive Plan; increase share reserve by 9,270,590 shares plus carryover from 2015 Plan.
- Ratified KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720580/000095017023026198/0000950170-23-026198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720580/000095017023026198/acet-20230601.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-026198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer